Wegovy wins approvals from MHRA as drug to help reduce risk of heart problems in people who are overweight
Health officials in the UK have given the green light for a weight-loss jab to be used to prevent heart attacks and strokes in overweight people.
Semaglutide, sold under the brand name Wegovy, has already been approved for weight management in people with obesity.